IBM Maximo Application Suite cross-site scripting
Key facts
- Attack vector
- Network
- Privileges required
- None
- User interaction
- Required
- Attack complexity
- Low
- Impact type
- Cross-site scripting
- Confidentiality · integrity · availability
- Low · Low · None
- Fix status
- No fix listed
Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-79.
Summary
IBM Maximo Application Suite 9.0.0 - Monitor Component is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Why it matters now
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- No
- Technical impact
- Partial
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
Remediation
No fixed version listed by the sources yet.
Timeline
- 2026-10-02 Threatist record created from CVE-2024-35145
- 2026-10-03 Alias added: GHSA-h64f-5gqh-pq98
References
More IBM Maximo Application Suite vulnerabilities
- TI-2025-24823 There is a vulnerability in the IBM Maximo Manage application in IBM Maximo Application Suite for Cognos Analytics CVSS 3.1CRITICAL 9.8
- TI-2024-18109 IBM Maximo Application Suite XML external entity injection CVSS 3.1HIGH 8.2
- TI-2025-02532 IBM Maximo Application Suite privilege escalation CVSS 3.1HIGH 8.8
- TI-2022-20121 IBM Maximo Asset Management information disclosure CVSS 3.1HIGH 7.5
- TI-2022-15959 IBM Maximo Application Suite command injection CVSS 3.1HIGH 8.8
- TI-2024-23228 IBM Maximo Application Suite SQL injection CVSS 3.1HIGH 8.8
Sources
- CVE-2024-35145 · CVE Program
- CVE-2024-35145 · NVD
- FIRST EPSS
- GHSA-h64f-5gqh-pq98 · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences